Medicinal cannabis is defined as the varieties of the Cannabis Sativa L plant, with a THC content of more than 0.2%.
Under law 4801/2021 (Government Gazette 83/Α’/24-05-2021) the production, export, and distribution of finished medical cannabis products of the Cannabis Sativa L plant species with a tetrahydrocannabinol (THC) content of more than 0.2% is allowed.
In Greece, the in so far approved cannabis indications are the following:
- Prevention and management of nausea and/or vomiting induced from chemotherapy
- Neuropathic pain, cancer pain, sustaining for more than 3 months and non-responsive to other treatments, or other treatments are non-tolerated or contraindicated
- Spasticity and pain in patients suffering from Multiple Sclerosis